002950.SZ SHZ
Allmed Medical Products Co.,Ltd
1W: -1.0%
1M: -7.1%
3M: -8.3%
YTD: -22.9%
1Y: -12.0%
3Y: -16.8%
5Y: -45.3%
¥8.54 ($1.27)
+0.12 (+1.43%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
$712M
+68.0% ▲
5Y CAGR: +21.1%
Capital Expenditures
$157M
+45.2% ▲
5Y CAGR: -7.6%
Free Cash Flow
$555M
+304.8% ▲
5Y CAGR: +68.7%
Dividends Paid
$44M
+32.4% ▲
Buybacks
$98M
+0.0% ▲
Net Change in Cash
$191M
+268.4% ▲
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | $1.2B | $432M | $405M | $110M | $369M |
| Depreciation & Amort. | $142M | $147M | $193M | $230M | $229M |
| Stock-Based Comp. | -$57M | -$27M | -$86M | $0 | $0 |
| Change in Working Capital | $224M | -$153M | $193M | -$16M | $69M |
| Other Non-Cash Items | -$90M | -$52M | $359M | $150M | $45M |
| Operating Cash Flow | $1.4B | $375M | $1.1B | $424M | $712M |
| — Investing Activities — | |||||
| Capital Expenditures | -$243M | -$291M | -$398M | -$286M | -$157M |
| Acquisitions (Net) | $329M | -$91M | -$99M | $774K | $0 |
| Investment Purchases | -$3.9B | -$3.0B | -$2.0B | -$212M | -$291M |
| Investment Sales | $3.3B | $2.9B | $1.5B | $351M | $295M |
| Other Investing | -$243M | -$8M | $1M | -$72M | $9M |
| Investing Cash Flow | -$745M | -$473M | -$971M | -$218M | -$145M |
| — Financing Activities — | |||||
| Net Debt Issuance | $623M | $47M | -$454M | -$206M | -$253M |
| Stock Repurchased | $0 | $0 | $0 | $0 | -$98M |
| Dividends Paid | -$253M | -$557M | -$133M | -$65M | -$44M |
| Other Financing | -$11M | -$42M | $350M | -$58M | $4M |
| Financing Cash Flow | $359M | -$553M | -$236M | -$329M | -$390M |
| Net Change in Cash | $1.1B | -$639M | -$160M | -$113M | $191M |
| Cash End of Period | $1.3B | $663M | $503M | $390M | $580M |
| Free Cash Flow | $1.2B | $84M | $752M | $137M | $555M |